Tulane Research Innovation for Arrhythmia Discovery
Actively recruiting patients for EDORA Clinical Trial.
TRIAD
Latest News
TRIAD Heads to HRX 2026
With 9 abstracts accepted for presentation, TRIAD is gearing up for HRX 2026 this September. Our team will share its latest findings and join...
HRS Meeting in Chicago 2026
TRIAD brought a strong scientific presence to Chicago, presenting 36 abstracts at Heart Rhythm 2026, the Heart Rhythm Society’s annual scientific...
“Burden Is the New Black”: Rethinking Success in AF Treatment
How much atrial fibrillation a patient experiences matters. In their January 2026 editorial in JACC: Clinical Electrophysiology, Dr. Nassir...
Publications
Zhao Y, Krupadev V, Dagher L, Mahnkopf C, Sohns C, Sehner S, Suling A, Sanders P, Boersma L, Schunkert H, Wegscheider K, Brachmann J, Marrouche NF.
J Interv Card Electrophysiol. 2020 Sep 4. doi: 10.1007/s10840-020-00856-1. Epub ahead of print. PMID: 32888121.
Impact of Left Ventricular Function and Heart Failure Symptoms on Outcomes Post Ablation of Atrial Fibrillation in Heart Failure: CASTLE-AF Trial.
Sohns C, Zintl K, Zhao Y, Dagher L, Andresen D, Siebels J, Wegscheider K, Sehner S, Boersma L, Merkely B, Pokushalov E, Sanders P, Schunkert H, Bänsch D, Mahnkopf C, Brachmann J, Marrouche NF.
Circ Arrhythm Electrophysiol. 2020 Oct;13(10):e008461. doi: 10.1161/CIRCEP.120.008461. Epub 2020 Sep 9. PMID: 32903044.


